These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6128632)

  • 1. Remission induction in acute myeloid leukaemia with oral etoposide.
    Evans JP; Prentice HG
    Lancet; 1982 Dec; 2(8311):1345-6. PubMed ID: 6128632
    [No Abstract]   [Full Text] [Related]  

  • 2. A phase II trial of VP 16-213 in adults with refractory acute myeloid leukemia. An Eastern Cooperative Oncology Group study.
    Bennett JM; Lymann GH; Cassileth PA; Glick JH; Oken MM
    Am J Clin Oncol; 1984 Oct; 7(5):471-3. PubMed ID: 6594926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide and teniposide in the treatment of acute leukemia.
    Björkholm M
    Med Oncol Tumor Pharmacother; 1990; 7(1):3-10. PubMed ID: 2187120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of acute myelocytic leukemia during the first recurrence by means of a new cytostatic combination].
    Cavalli F; Sauter C; Senn HJ; Alberto P
    Schweiz Med Wochenschr; 1976 Sep; 106(38):1265-8. PubMed ID: 1070154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amsacrine and etoposide induced paralytic ileus in a patient with acute myelomonocytic leukemia.
    Kucuk O; Apostol JV
    J Surg Oncol; 1985 Mar; 28(3):172-3. PubMed ID: 3856083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid remission induction in adult acute non-lymphoblastic leukaemia.
    Dubovsky D; Kernoff L; Jacobs P
    Eur J Cancer (1965); 1978 Nov; 14(11):1179-83. PubMed ID: 738325
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Epipodophyllotoxin VP 16213 in acute non-lymphoblastic leukaemia.
    Cavalli F; Sonntag R; Brunner KW
    Br Med J; 1975 Oct; 4(5990):227. PubMed ID: 1059494
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-term oral administration of etoposide (VP-16) for the patients with refractory or relapsed acute non-lymphocytic leukemia].
    Koyama S; Saitou H; Kashiwaba M
    Rinsho Ketsueki; 1991 Jul; 32(7):736-42. PubMed ID: 1920837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etoposide in remission induction of adult acute myeloid leukemia.
    Leoni F; Ciolli S; Patriarchi S; Morfini M; Rossi Ferrini P
    Acta Haematol; 1990; 83(2):82-5. PubMed ID: 2106200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VP 16-213 in acute myelogenous leukaemia.
    Smith IE; Gerken ME; Clink HM; McElwain TJ
    Postgrad Med J; 1976 Feb; 52(604):66-70. PubMed ID: 772645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etoposide in the treatment of acute leukemia in adults.
    Varini M; Cavalli F; Sauter C
    Cancer Treat Rev; 1982 Jun; 9 Suppl():59-62. PubMed ID: 7127335
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose cytosine arabinoside plus etoposide as initial treatment for acute myeloid leukaemia: a single centre study.
    Parikh P; Powles R; Treleaven J; Helenglass G; Gore M; Rose M; Talbot D; Milan S; Smith C; Pinkerton R
    Br J Cancer; 1990 Nov; 62(5):830-3. PubMed ID: 2245176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose VP 16-213 (NSC 141540) for the treatment of patients with previously treated acute leukemia.
    Van Echo DA; Wiernik PH; Aisner J
    Cancer Clin Trials; 1980; 3(4):325-8. PubMed ID: 6933027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A phase II trial of etoposide (VP-16) administered intravenously in the treatment of malignant lymphoma and acute leukemia].
    Moriyama Y; Shibata A; Maekawa I; Yoshida Y; Miura A; Wakui A; Kariyone S; Maekawa T; Miura Y; Abe T
    Rinsho Ketsueki; 1985 Nov; 26(11):1774-84. PubMed ID: 3835288
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute myeloid leukemia complicating multiple myeloma: a case successfully treated with etoposide, thioguanine, and cytarabine.
    Erikci AA; Ozturk A; Tekgunduz E; Sayan O
    Clin Lymphoma Myeloma; 2009 Aug; 9(4):E14-5. PubMed ID: 19717372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute monocytic leukemia and acute myelomonocytic leukemia: treatment using VP 16213].
    Amiel JL; Schwarzenberg L; Musset M; De Vassal F; Hayat M; Mathé G
    Bull Cancer; 1974; 61(3):419-26. PubMed ID: 4533742
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic myelomonocytic leukaemia: a case report.
    Gétaz EP; Staples WG
    S Afr Med J; 1977 Jun; 51(23):852-3. PubMed ID: 267330
    [No Abstract]   [Full Text] [Related]  

  • 18. VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules.
    Cavalli F; Sonntag RW; Jungi F; Senn HJ; Brunner KW
    Cancer Treat Rep; 1978 Mar; 62(3):473-5. PubMed ID: 348319
    [No Abstract]   [Full Text] [Related]  

  • 19. Simple method for the administration of high-dose etoposide during autologous bone marrow transplantation.
    Lazarus HM; Creger RJ; Diaz D
    Cancer Treat Rep; 1986 Jun; 70(6):819-20. PubMed ID: 3524832
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic experiences using the new podophyllotoxin derivative VP 16-213 in malignant human tumors].
    Jungi WF; Senn HJ; Beckmann C; Flury R; Frei P; Holdener E
    Schweiz Med Wochenschr; 1975 Oct; 105(42):1365-9. PubMed ID: 179137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.